Taysha Gene Therapies, Inc. SEC filings TSHA

Taysha Gene Therapies, Inc. has 401 filings in SEC EDGAR's recent list, going back to May 4, 2020. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations). The company's fiscal year ends on December 31.

Taysha Gene Therapies, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Aug 11, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 11, 2026 Aug 11, 2026
8-K Current report
Material agreement, Other events
Jun 25, 2026 Jun 24, 2026
424B5 Prospectus supplement Jun 25, 2026 —
424B5 Prospectus supplement Jun 24, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Jun 22, 2026 Jun 22, 2026
8-K Current report
Shareholder vote results
Jun 2, 2026 Jun 1, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
ARS Annual report to shareholders Apr 22, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 22, 2026 —
DEF 14A Proxy statement Apr 22, 2026 Jun 1, 2026
10-K Annual report Mar 19, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 19, 2026 Mar 19, 2026
S-8 Employee stock plan registration Jan 6, 2026 —
S-3ASR Automatic shelf registration Nov 4, 2025 —
8-K Current report
Material agreement, Results of operations
Nov 4, 2025 Nov 4, 2025
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Other events
Oct 16, 2025 Oct 16, 2025
8-K Current report
Other events
Oct 9, 2025 Oct 9, 2025
8-K Current report
Other events
Oct 2, 2025 Oct 2, 2025
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 12, 2025 Aug 12, 2025
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 3, 2025 Jun 2, 2025
8-K Current report
Material agreement, Other events
May 29, 2025 May 28, 2025
424B5 Prospectus supplement May 29, 2025 —
8-K/A Amended current report
Regulation FD disclosure, Other events
May 29, 2025 May 28, 2025
424B5 Prospectus supplement May 28, 2025 —
8-K Current report
Regulation FD disclosure, Other events
May 28, 2025 May 28, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 15, 2025 May 15, 2025
DEFR14A Filing May 9, 2025 —
ARS Annual report to shareholders Apr 21, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 21, 2025 —
DEF 14A Proxy statement Apr 21, 2025 Jun 2, 2025
PRE 14A Preliminary proxy statement Apr 10, 2025 Jun 2, 2025
10-K Annual report Feb 26, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 26, 2025 Feb 26, 2025
S-8 Employee stock plan registration Jan 7, 2025 —
EFFECT Filing Dec 20, 2024 —
CORRESP Letter to the SEC Dec 20, 2024 —
CORRESP Letter to the SEC Dec 19, 2024 —
UPLOAD Letter from the SEC Dec 18, 2024 —
S-3 Shelf registration Dec 13, 2024 —
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 13, 2024 Nov 13, 2024
10-Q Quarterly report Aug 12, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 12, 2024 Aug 12, 2024
8-K Current report
Material agreement, Other events
Jun 26, 2024 Jun 26, 2024
424B5 Prospectus supplement Jun 26, 2024 —
8-K Current report
Results of operations, Other events
Jun 26, 2024 Jun 25, 2024
424B5 Prospectus supplement Jun 26, 2024 —
8-K Current report
Regulation FD disclosure
Jun 18, 2024 Jun 18, 2024
8-K Current report
Shareholder vote results
May 30, 2024 May 29, 2024
8-K Current report
Results of operations
May 14, 2024 May 14, 2024
10-Q Quarterly report May 14, 2024 Mar 31, 2024
DEFA14A Additional proxy material Apr 18, 2024 —
ARS Annual report to shareholders Apr 18, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 18, 2024 May 29, 2024
S-8 Employee stock plan registration Mar 19, 2024 —
8-K Current report
Results of operations
Mar 19, 2024 Mar 19, 2024
10-K Annual report Mar 19, 2024 Dec 31, 2023
8-K Current report
Regulation FD disclosure
Jan 10, 2024 Jan 10, 2024
8-K Current report
Officer or director change
Dec 20, 2023 Dec 14, 2023
S-8 Employee stock plan registration Dec 20, 2023 —
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Nov 15, 2023 Nov 15, 2023
8-K Current report
Results of operations
Nov 14, 2023 Nov 14, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Officer or director change
Nov 1, 2023 Oct 30, 2023
DEF 14A Proxy statement Oct 5, 2023 Nov 15, 2023
8-K Current report
Regulation FD disclosure
Sep 26, 2023 Sep 26, 2023
PRE 14A Preliminary proxy statement Sep 21, 2023 Nov 15, 2023
8-K Current report
Other events
Sep 19, 2023 Sep 19, 2023
424B3 Prospectus Sep 11, 2023 —
EFFECT Filing Sep 8, 2023 —
CORRESP Letter to the SEC Sep 7, 2023 —
UPLOAD Letter from the SEC Sep 6, 2023 —
S-3 Shelf registration Aug 30, 2023 —
8-K Current report
Other events
Aug 29, 2023 Aug 28, 2023
D Filing Aug 25, 2023 —
8-K Current report
Other events
Aug 24, 2023 Aug 24, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
8-K Current report
Material agreement, Results of operations, Unregistered share sale, Other events
Aug 14, 2023 Aug 14, 2023
8-K Current report
Listing notice
Aug 4, 2023 Aug 3, 2023
8-K Current report
Regulation FD disclosure
Jul 31, 2023 Jul 31, 2023
8-K Current report
Regulation FD disclosure
Jun 28, 2023 Jun 28, 2023
8-K Current report
Shareholder vote results
Jun 23, 2023 Jun 22, 2023
8-K Current report
Officer or director change
Jun 22, 2023 Jun 20, 2023
8-K Current report
Officer or director change
Jun 6, 2023 May 31, 2023
8-K Current report
Other events
Jun 5, 2023 Jun 5, 2023
8-K Current report
Other events
May 19, 2023 May 19, 2023
8-K Current report
Results of operations
May 15, 2023 May 11, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
ARS Annual report to shareholders May 8, 2023 Dec 31, 2022
DEFA14A Additional proxy material May 8, 2023 —
DEF 14A Proxy statement May 8, 2023 Jun 22, 2023
424B3 Prospectus May 4, 2023 —
EFFECT Filing May 1, 2023 —
CORRESP Letter to the SEC Apr 27, 2023 —
8-K Current report
Listing notice, Officer or director change
Apr 27, 2023 Apr 24, 2023
PRE 14A Preliminary proxy statement Apr 27, 2023 Jun 22, 2023
10-K/A Amended annual report Apr 27, 2023 Dec 31, 2022
UPLOAD Letter from the SEC Apr 7, 2023 —
S-3 Shelf registration Apr 5, 2023 —
424B5 Prospectus supplement Mar 29, 2023 —
S-8 Employee stock plan registration Mar 28, 2023 —
10-K Annual report Mar 28, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 28, 2023 Mar 28, 2023
8-K/A Amended current report
Officer or director change
Mar 8, 2023 Dec 16, 2022
8-K Current report
Other events
Jan 31, 2023 Jan 31, 2023
8-K Current report
Officer or director change
Jan 19, 2023 Jan 12, 2023
8-K/A Amended current report
Officer or director change
Jan 6, 2023 Dec 16, 2022
8-K Current report
Officer or director change, Other events
Dec 22, 2022 Dec 16, 2022
10-Q Quarterly report Nov 8, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 8, 2022 Nov 8, 2022
D Filing Nov 7, 2022 —
8-K/A Amended current report
Material agreement, Unregistered share sale, Other events
Oct 31, 2022 Oct 21, 2022
8-K Current report
Material agreement, Other events
Oct 27, 2022 Oct 26, 2022
424B5 Prospectus supplement Oct 27, 2022 —
8-K Current report
Results of operations, Other events
Oct 25, 2022 Oct 25, 2022
424B5 Prospectus supplement Oct 25, 2022 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Oct 25, 2022 Oct 21, 2022
8-K Current report
Regulation FD disclosure
Sep 9, 2022 Sep 9, 2022
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 11, 2022 Aug 11, 2022
8-K Current report
Shareholder vote results
Jun 21, 2022 Jun 17, 2022
10-Q Quarterly report May 16, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 16, 2022 May 16, 2022
DEFA14A Additional proxy material Apr 28, 2022 —
DEF 14A Proxy statement Apr 28, 2022 Jun 17, 2022
424B5 Prospectus supplement Mar 31, 2022 —
S-8 Employee stock plan registration Mar 31, 2022 —
10-K Annual report Mar 31, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 31, 2022 Mar 31, 2022
8-K Current report
Other events
Jan 31, 2022 Jan 31, 2022
8-K Current report
Other events
Jan 27, 2022 Jan 27, 2022
10-Q Quarterly report Nov 10, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 10, 2021 Nov 10, 2021
EFFECT Filing Oct 14, 2021 —
CORRESP Letter to the SEC Oct 12, 2021 —
UPLOAD Letter from the SEC Oct 12, 2021 —
S-3 Shelf registration Oct 5, 2021 —
8-K Current report
Other events
Oct 5, 2021 Oct 5, 2021
10-Q Quarterly report Aug 16, 2021 Jun 30, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Aug 16, 2021 Aug 16, 2021
8-K Current report
Regulation FD disclosure
Jun 29, 2021 Jun 29, 2021
8-K Current report
Regulation FD disclosure
Jun 28, 2021 Jun 28, 2021
8-K Current report
Shareholder vote results
Jun 17, 2021 Jun 17, 2021
S-8 Employee stock plan registration May 11, 2021 —
10-Q Quarterly report May 11, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 11, 2021 May 11, 2021
DEF 14A Proxy statement Apr 29, 2021 Jun 17, 2021
8-K Current report
Regulation FD disclosure, Other events
Apr 14, 2021 Apr 14, 2021
8-K Current report
Other events
Apr 12, 2021 Apr 12, 2021
8-K Current report
Other events
Mar 9, 2021 Mar 9, 2021
8-K/A Amended current report
Results of operations
Mar 5, 2021 Nov 12, 2020
10-K Annual report Mar 3, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 3, 2021 Mar 3, 2021
8-K Current report
Other events
Feb 12, 2021 Feb 9, 2021
8-K Current report
Other events
Feb 1, 2021 Feb 1, 2021
8-K Current report
Other events
Jan 19, 2021 Jan 19, 2021
8-K Current report
Material agreement, New debt
Jan 15, 2021 Jan 11, 2021
8-K Current report
Other events
Dec 21, 2020 Dec 21, 2020
8-K Current report
Material agreement, New debt, Other events
Dec 17, 2020 Dec 17, 2020
8-K Current report
Other events
Dec 3, 2020 Dec 3, 2020
8-K Current report
Officer or director change, Regulation FD disclosure
Nov 24, 2020 Nov 23, 2020
10-Q Quarterly report Nov 12, 2020 Sep 30, 2020
8-K Current report
Acquisition or sale of assets
Nov 12, 2020 Nov 12, 2020
8-K Current report
Other events
Nov 5, 2020 Nov 5, 2020
8-K Current report
Material agreement
Nov 4, 2020 Oct 29, 2020
8-K Current report
Other events
Oct 27, 2020 Oct 27, 2020
8-K Current report
Other events
Oct 14, 2020 Oct 14, 2020
8-K Current report
Other events
Oct 7, 2020 Oct 6, 2020
8-K Current report
Bylaw or fiscal year change
Sep 29, 2020 Sep 28, 2020
S-8 Employee stock plan registration Sep 29, 2020 —
424B4 Prospectus Sep 25, 2020 —
SEC STAFF LETTER Filing Sep 23, 2020 —
EFFECT Filing Sep 23, 2020 —
S-1MEF Filing Sep 23, 2020 —
CERT Filing Sep 23, 2020 —
CORRESP Letter to the SEC Sep 21, 2020 —
CORRESP Letter to the SEC Sep 21, 2020 —
8-A12B Filing Sep 18, 2020 —
S-1/A Amended registration statement Sep 18, 2020 —
CORRESP Letter to the SEC Sep 17, 2020 —
S-1/A Amended registration statement Sep 17, 2020 —
UPLOAD Letter from the SEC Sep 16, 2020 —
SEC STAFF LETTER Filing Sep 11, 2020 —
CORRESP Letter to the SEC Sep 8, 2020 —
S-1/A Amended registration statement Sep 8, 2020 —
S-1 Registration statement Sep 2, 2020 —
UPLOAD Letter from the SEC Sep 2, 2020 —
D Filing Aug 18, 2020 —
DRS Filing Aug 3, 2020 —
D Filing May 4, 2020 —

Showing 195 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
TSHA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Dallas, TX
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1806310

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.